Preliminary Program
Welcome – Agenda
State of play with Vaccination Standards in Europe: an overview
Christof Gessner, HL7 Europe Board of Directors, HL7 Germany
What is the state of play of implementations across Europe?
Role of HL7 Standards? Role of Affiliates?
collaborations – decision-making practices – vendor engagement?
Vaccination Standardization Efforts across Europe (deep dive, 10 min each)
Line Saele Andreassen, HL7 Europe Board of Directors, HL7 Norway, Public Health Agency of Norway
Giorgio Cangioli, HL7 Europe Board of Directors, HL7 Italy
Roeland Luykx, HL7 Switzerland
Panel statements (Limit to 5 minutes each)
Eamon Coyne, Enterprise Technical Architecture Lead, Health Services Executive Ireland
Jose Costa Teixeira, HL7 Belgium
Jens Kristian Villadsen, HL7 Europe Board of Directors, HL7 Denmark
HL7 France Representative (TBC)
Sylvia Thun, HL7 Germany
Discussion (25 min)
HL7 as an organization has been a catalyst for health information technology standards since the times of HL7v2 and remains a catalyst with HL7 CDA and HL7 FHIR large scale projects as myHealth@EU and eHDSI introducing new ways of developing standards and accelerating their adoption.
Quite timely as we are implementing proof of vaccination for medical and other purposes across Europe and beyond.
Following the speaker talks, the following questions will be addressed in a panel:
How do you see the role of HL7 Europe and European affiliates supporting the proof of vaccination for medical purposes in the COVID-19 pandemic?
What synergies work well in these circumstances? Where more work is needed?
How did you or members of your HL7 Affiliate contribute to national or European specifications for proof of vaccinations?
How do you see the HL7 user communities evolving into the future to support alignment of standards?
How do you see the connection to interoperability policy for research, public health and data science?
Closing Remarks: Catherine Chronaki, HL7 Europe (5min)
The UNICOM Innovation Action has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 875299.
